
American Oriental Bioengineering, Inc. – OTC:AOBI
American Oriental Bioengineering stock price today
American Oriental Bioengineering stock price monthly change
American Oriental Bioengineering stock price quarterly change
American Oriental Bioengineering stock price yearly change
American Oriental Bioengineering key metrics
Market Cap | 72.99K |
Enterprise value | 89.53M |
P/E | N/A |
EV/Sales | 0.73 |
EV/EBITDA | -1.19 |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -755.32 |
Revenue | 59.16M |
EBITDA | -37.97M |
Income | -55.13M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -74.86% |
Oper. margin | -64.27% |
Gross margin | 32.59% |
EBIT margin | -64.27% |
EBITDA margin | -64.18% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAmerican Oriental Bioengineering stock price history
American Oriental Bioengineering stock forecast
American Oriental Bioengineering financial statements
Sep 2013 | 17.93M | -21.17M | -118.06% |
---|
Sep 2013 | 427624938 | 143.94M | 33.66% |
---|
Sep 2013 | -17.05M | -13.27M | 25.86M |
---|
American Oriental Bioengineering alternative data
Aug 2023 | 3,719 |
---|---|
Sep 2023 | 3,719 |
Oct 2023 | 3,719 |
Nov 2023 | 3,719 |
Dec 2023 | 3,719 |
Jan 2024 | 3,719 |
Feb 2024 | 3,719 |
Mar 2024 | 3,719 |
Apr 2024 | 3,719 |
May 2024 | 3,719 |
Jun 2024 | 3,719 |
Jul 2024 | 3,719 |
American Oriental Bioengineering other data
-
What's the price of American Oriental Bioengineering stock today?
One share of American Oriental Bioengineering stock can currently be purchased for approximately $0.
-
When is American Oriental Bioengineering's next earnings date?
Unfortunately, American Oriental Bioengineering's (AOBI) next earnings date is currently unknown.
-
Does American Oriental Bioengineering pay dividends?
No, American Oriental Bioengineering does not pay dividends.
-
How much money does American Oriental Bioengineering make?
American Oriental Bioengineering has a market capitalization of 72.99K.
-
What is American Oriental Bioengineering's stock symbol?
American Oriental Bioengineering, Inc. is traded on the OTC under the ticker symbol "AOBI".
-
What is American Oriental Bioengineering's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of American Oriental Bioengineering?
Shares of American Oriental Bioengineering can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does American Oriental Bioengineering have?
As Jul 2024, American Oriental Bioengineering employs 3,719 workers.
-
When American Oriental Bioengineering went public?
American Oriental Bioengineering, Inc. is publicly traded company for more then 23 years since IPO on 12 Dec 2001.
-
How can i contact American Oriental Bioengineering?
American Oriental Bioengineering can be reached via phone at +86 10 5982 2039.
American Oriental Bioengineering company profile:
OTC
3,719
Biotechnology
Healthcare
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.
Beijing, 100176
:
ISIN: US0287315032
: